TwinBeech Capital’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
TwinBeech Capital's RGEN Position: Q2 2026 in Review
TwinBeech Capital sold out of Repligen (RGEN) in Q2 2026, closing a stake of 13,500 shares — an estimated $1.59M sold.
TwinBeech Capital first reported a position in RGEN in Q3 2020 and held it in 6 quarters. The position peaked at $11.7M in Q2 2025. 478 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- TwinBeech Capital reported no remaining Repligen position as of Q2 2026 after selling out during the quarter.
- TwinBeech Capital sold 13,500 Repligen shares in Q2 2026, an estimated $1.59M.
- TwinBeech Capital first reported a position in Repligen in Q3 2020 and held it in 6 quarters.
- TwinBeech Capital's Repligen position peaked at $11.7M in Q2 2025.
- 478 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on TwinBeech Capital's 13F filing for Q2 2026, filed 14 Aug 2026.